Cash & equivalents increased 54.7%
Cash & equivalents changed +54.7% from the comparable as-filed period. The change ranks at the 46th percentile of 213 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +54.7% from the comparable as-filed period. The change ranks at the 46th percentile of 213 prior comparable changes.
Net income changed +386.1% from the comparable as-filed period. The change ranks at the 95th percentile of 117 prior comparable changes.
Operating income changed +441.4% from the comparable as-filed period. The change ranks at the 97th percentile of 116 prior comparable changes.
Operating margin changed +1309 basis points from the comparable as-filed period. The change ranks at the 96th percentile of 116 prior comparable changes.
Inventory changed -10.7% from the comparable as-filed period. The change ranks at the 73th percentile of 110 prior comparable changes.
Revenue changed +19.8% from the comparable as-filed period. The change ranks at the 63th percentile of 116 prior comparable changes.
Selling, general & administrative changed -11.0% from the comparable as-filed period. The change ranks at the 68th percentile of 116 prior comparable changes.
Research & development changed -2.9% from the comparable as-filed period. The change ranks at the 18th percentile of 116 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.